Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Blood-retina barrier failure and vision loss in neuron-specific degeneration
Elena Ivanova, … , Glen T. Prusky, Botir T. Sagdullaev
Elena Ivanova, … , Glen T. Prusky, Botir T. Sagdullaev
Published March 19, 2019
Citation Information: JCI Insight. 2019;4(8):e126747. https://doi.org/10.1172/jci.insight.126747.
View: Text | PDF
Research Article Ophthalmology Vascular biology

Blood-retina barrier failure and vision loss in neuron-specific degeneration

  • Text
  • PDF
Abstract

Changes in neuronal activity alter blood flow to match energy demand with the supply of oxygen and nutrients. This functional hyperemia is maintained by interactions among neurons, vascular cells, and glia. However, how changing neuronal activity prevalent at the onset of neurodegenerative disease affects neurovascular elements is unclear. Here, in mice with photoreceptor degeneration, a model of neuron-specific dysfunction, we combined the assessment of visual function, neurovascular unit structure, and blood-retina barrier permeability. We found that the rod loss paralleled remodeling of the neurovascular unit, comprising photoreceptors, retinal pigment epithelium, and Muller glia. When substantial visual function was still present, blood flow became disrupted and the blood-retina barrier began to fail, facilitating cone loss and vision decline. Thus, in contrast to the established view, the vascular deficit in neuronal degeneration is not a late consequence of neuronal dysfunction but is present early in the course of disease. These findings further establish the importance of vascular deficit and blood-retina barrier function in neuron-specific loss and highlight it as a target for early therapeutic intervention.

Authors

Elena Ivanova, Nazia M. Alam, Glen T. Prusky, Botir T. Sagdullaev

×

Figure 8

Emergence of blood-retina barrier elements in choroid where retinal pigment epithelium is compromised.

Options: View larger image (or click on image) Download as PowerPoint
Emergence of blood-retina barrier elements in choroid where retinal pigm...
(A–C) In WT eyecup preparation, stained for claudin5, PLVAP, and albumin, no labeling is visible through pigmented retinal pigment epithelium (RPE) cells. (D–F) In pigmented mice from A–C, RPE cells were removed after the eyecup preparation was imaged. (D–I) In WT pigmented and albino mice, choroid capillaries expressed PLVAP (magenta) and did not express claudin5 (green). In contrast, large, sparse, deeply positioned choroid blood vessels were positive for claudin5 and negative for PLVAP (arrow). (J–L) In rd10 mice at P70, exposed capillaries of choroid had no claudin5 expression. Due to the absence of photoreceptors, retinal blood vessels became visible (arrowheads). The arrow shows large choroid blood vessels behind choroid capillary layer. (M–O) At P210 in rd10, choroid gained claudin5 expression in the bare patches without RPE cells (circled). (P–R) In the absence of RPE labeled for Cx43 (green), choroid became exposed and leaky (blue). (S and T) Muller glia, immunostained for glutamine synthetase (GS, blue), were associated with the exposed choroid (outlined by the dashed line). (U) Exposed choroid was mostly present in the central retina. Scale bars: 0.1 μm. Average ± SD (6 mice). Two-tailed t test, ***P < 0.001. PLVAP, plasmalemma vesicle-associated protein; alb, albumin; Cx43, connexin43.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts